Seminars in Arthroplasty
Volume 21, Issue 2 , Pages 85-86 , June 2010

Deep Vein Thrombosis Prophylaxis: Better Living Through Chemistry—Opposes

  • Clifford W. Colwell Jr, MD

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Clifford W. Colwell Jr, MD, Center for Orthopaedic Research and Education at Scripps Clinic, 11025 North Torrey Pines Rd., Suite 140, La Jolla, CA 92037

References 

  1. Prevention of venous thrombosis and pulmonary embolism (NIH Consensus Development). JAMA. 1986;256:744–749
  2. Johanson NA, Lachiewicz PF, Lieberman JR, et al. Prevention of symptomatic pulmonary embolism in patients undergoing total hip or knee arthroplasty. J Am Acad Orthop Surg. 2009;17:183–196
  3. Geerts WH, Bergqvist D, Pineo GF, et al. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (ed 8). Chest. 2008;133(suppl 6):381S–453S
  4. Ben Galim P, Steinberg EL, Rosenblatt Y, et al. A miniature and mobile intermittent pneumatic compression device for the prevention of deep-vein thrombosis after joint replacement. Acta Orthop Scand. 2004;75:584–587
  5. Gelfer Y, Tavor H, Oron A, et al. Deep vein thrombosis prevention in joint arthroplasties: Continuous enhanced circulation therapy vs low molecular weight heparin. J Arthroplasty. 2006;21:206–214
  6. Edwards JZ, Pulido PA, Ezzet KA, et al. Portable compression device and low-molecular-weight heparin compared with low-molecular-weight heparin for thromboprophylaxis after total joint arthroplasty. J Arthroplasty. 2008;23:1122–1127

PII: S1045-4527(09)00086-8

doi: 10.1053/j.sart.2009.12.003

Seminars in Arthroplasty
Volume 21, Issue 2 , Pages 85-86 , June 2010

Article Tools